Move Over, Mother Nature

Synthetic biologists harness software to design genes and networks.

Written byAmber Dance
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

GRAND VISION, ROUND 1: With Genome Compiler, you can look at your syntheses on a variety of levels, from the nucleotides to the peptides to the whole organism. GENOME COMPILER MEDIA TEAM

Working at the crossroads of biology and engineering, synthetic biologists are crafting genes, proteins, and organisms that evolution never came up with. They are creating bacteria that produce biofuels and yeast cells that manufacture medicines. They are swapping promoters, ribosome-binding sequences, and open reading frames as if they were Lego bricks.

“We are no longer constrained by what Mother Nature gives us,” says Claes Gustafsson, cofounder of the DNA synthesis company DNA2.0, in Menlo Park, California.

Now, the constraint is the toolkit. Traditional biologists can work with DNA sequences using a simple viewer or editor, but “the engineers need a whole new suite of tools,” says Natalie Kuldell, who teaches biological engineering at MIT.

The synthetic biologist’s mind-set is all about parts, those nucleic acid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Amber Dance is an award-winning freelance science journalist based in Southern California. After earning a doctorate in biology, she re-trained in journalism as a way to engage her broad interest in science and share her enthusiasm with readers. She mainly writes about life sciences, but enjoys getting out of her comfort zone on occasion.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies